Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction - Wikidata - awgldk - TriplyDB

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

http://www.wikidata.org/entity/Q33886695

about

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis Osteoimmunology: interactions of the bone and immune system A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis Bone loss. Factors that regulate osteoclast differentiation: an update.The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.Anti-cytokine therapy in chronic destructive arthritis Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis The molecular mechanism of osteoclastogenesis in rheumatoid arthritis A review of UHMWPE wear-induced osteolysis: the role for early detection of the immune response.Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts Effects of anti-tumor necrosis factor α agents on bone Targeting TNF receptors in rheumatoid arthritis Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8 Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective Tumor necrosis factor- α and interleukin-6: potential interorgan inflammatory mediators contributing to destructive periodontal disease in obesity or metabolic syndrome Functional Local Renin-Angiotensin System in Human and Rat Periodontal Tissue Cytosolic Hsp60 is involved in the NF-kappaB-dependent survival of cancer cells via IKK regulation Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo Disorders of bone remodeling RANKL-induced DC-STAMP is essential for osteoclastogenesis Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss.SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review.Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts.TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction.NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors.Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo.Cell-cell interaction promotes rat marrow stromal cell differentiation into endothelial cell via activation of TACE/TNF-alpha signaling.Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro.Current developments in salivary diagnostics.HIV associated hypocalcaemia among diarrheic patients in northwest Ethiopia: a cross sectional study.Contradictory Role of CD97 in Basal and Tumor Necrosis Factor-Induced Osteoclastogenesis In Vivo.The effects of proteasome inhibitors on bone remodeling in multiple myeloma.Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation

P2860

Q21092154-EE7CE2B7-172B-4AFC-AB6C-FAA716E8ABCA Q24311417-DEDB549B-A326-4152-913A-5C8A7F5B9B57 Q24655113-3DB0D765-5DAD-4DF3-97E7-2AB022650059 Q24799036-0D0D023C-10F2-4112-92CD-D2915F1A3CD7 Q24800726-70291D53-2783-4903-9920-E03C8A8D469C Q24805142-7E128DFB-3C16-404B-A16E-4B30BFF27344 Q24805207-C25B51AB-5165-4366-8F4B-4A3147E3BD5B Q24805245-8D1C404D-F175-426D-803E-5E06D6BAD0DE Q24805600-85A6ED3C-708C-4BD0-A18D-6BC5F673E147 Q24806322-AEA16B09-E137-4418-BC59-F4F0DF5E97C8 Q26741081-F8DF471A-B3BB-44F5-B785-9BD658E97281 Q26774874-3B808F2A-F2A7-4698-9D80-58A5A1FB57E5 Q26828486-872AEB7B-EDE9-4FE9-8669-61DC193ED69E Q26851274-924EBEC5-E6BB-4735-AA7D-8954ED056B68 Q26853279-0357A1EE-6426-4F6A-92D9-AA9BCE14EFA7 Q26863571-D956D644-8693-4EC7-8E66-2720370C4BE8 Q26991927-4A80927D-FABD-44A4-9D18-57CA6611E4C2 Q27021308-8C655B41-E446-49FE-A49C-EC89F2A5280F Q27301201-3B7CB256-3B70-4A3A-ACDD-5D615E260FF4 Q27334016-D730470C-FE28-48DA-AE1D-5C6F20BFDEA6 Q28191731-3B270BB6-D35F-4A12-9D4A-D7B2FC9F07B1 Q28295303-09C610CB-CFF4-4E2D-8D03-52E00A0B07B5 Q28504881-A1219307-07E4-4078-8501-BBE6D5D71BB9 Q28593488-0D18807B-7B4E-4CCB-BBCD-7742076C3A2F Q30009262-93316F33-69BE-44D2-A6CD-5DCF209F8615 Q30009390-180AF663-38DE-444F-A795-BC796BCEF887 Q30009398-9BC8977D-9A81-4FFC-8DEA-A4272BBBF670 Q30251957-CEE3A08A-EB82-43CF-9107-83557CBE7998 Q30278787-1B7B301C-E442-496B-9C7C-1134F030E467 Q30396344-495C3B05-55EE-4E90-AB01-5C95A2EE0798 Q33706001-560CCE4D-30BF-47F9-84BE-E58A731C1264 Q33719492-5F3E1F52-2D68-4154-9379-B60350D23CDA Q33742652-403F6477-439E-4CF8-AD4A-7758EAA15A61 Q33774545-6108C970-38C0-405F-AD22-81B3C03F09CF Q33784120-96446168-3917-432B-9305-90071B2CA7E1 Q33803001-35469479-0E02-4819-BF04-6F96AB38C8ED Q33907278-6305F553-1A3E-45FB-B182-A0D7B63261E9 Q33912625-E3C96ACF-BD4F-44EA-86D8-76908D87A480 Q33918020-5A8C9AD2-7812-48A7-BBC4-9C1A8A6CAB36 Q33946711-660DAF3A-78B9-475C-9169-9AA5556A464B

P2860

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

http://www.wikidata.org/entity/Q33886695

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

name

Tumor necrosis factor alpha st ...... the ODF/RANKL-RANK interaction

@ast

Tumor necrosis factor alpha st ...... the ODF/RANKL-RANK interaction

@en

type

label

Tumor necrosis factor alpha st ...... the ODF/RANKL-RANK interaction

@ast

Tumor necrosis factor alpha st ...... the ODF/RANKL-RANK interaction

@en

prefLabel

Tumor necrosis factor alpha st ...... the ODF/RANKL-RANK interaction

@ast

Tumor necrosis factor alpha st ...... the ODF/RANKL-RANK interaction

@en

P1433

Q33886695-446F3B08-152D-47E6-99E6-9D22F5132B74

P1476

Q33886695-FB2A6893-0FED-4BF7-960B-D0CFD7FFE131

P2093

Q33886695-3ED4A4ED-8534-44A1-9A0D-854C42BC86C1

Q33886695-3F47B681-2AB3-4996-B650-CD58E627DEB8

Q33886695-40FFAA93-3DF2-4E03-821F-C778EF65BDB5

Q33886695-544AB7AD-F644-4755-A1AA-6A400B731AC6

Q33886695-5E07E4CA-C3B4-48AA-AC09-F6E07C2DCD0A

Q33886695-661B5FA6-88AE-4B8E-9221-80704FE002E9

Q33886695-943B643E-ED51-43B8-9A0C-13B4931CB420

Q33886695-991F04DA-69B6-4421-B7F8-D38881C6A92C

Q33886695-AAABADCD-E36E-4FF8-8368-DDFE3BF2AE5B

Q33886695-AE740268-7507-496B-B14D-61CA3E0FE425

P2860

Q33886695-08F05491-A7A7-48F8-9DF2-3BF54253E67D

Q33886695-0C569B44-DB81-4B8C-B64E-7300D7C9F623

Q33886695-12B16BE8-A089-4696-BB8F-B468B26F5F74

Q33886695-174E7636-B87F-490C-9AB0-12D5A4D52D7B

Q33886695-1CE4A298-8EAD-41A2-A799-64F09AD7A7B5

Q33886695-28803C0A-A567-4874-B369-B5C6149B0776

Q33886695-2A77D714-BDA0-48D9-8BCA-4DD693C7D07D

Q33886695-2DBF6EE5-103C-4E69-BBD7-E5DA6F8A0ABB

Q33886695-320ADFF1-4F75-4CB0-8381-965BFA073F41

Q33886695-3418FB40-8359-463D-98C8-F0CE058D2251

P304

Q33886695-82E36C1C-82B1-46DA-B4FE-2D5AE9F43DA9

P31

Q33886695-77C9B76B-CC90-4F5F-938A-0F67D9FE3855

P356

Q33886695-BE29B992-4EC0-4635-95A6-0FF66A31AE07

P407

Q33886695-8A5D0170-F8A1-47CE-AD0F-7350788F1A94

P433

Q33886695-4CAC4A88-A421-422E-A0BB-6231E85D1D95

P478

Q33886695-90358D19-3D1E-43A1-88F7-0378815F9079

P50

Q33886695-4019232C-ACC5-474F-A798-37DAFC1974BC

P577

Q33886695-CA309C1B-E191-41D2-91D3-614A7FDDAF12

P698

Q33886695-D290711C-BA79-4AEF-91FA-B1D4E6C73B6A

P932

Q33886695-6D892435-22AA-461C-8A02-E63EB48A7EE4

P356

P1433

Journal of Experimental Medicine

P1476

Tumor necrosis factor alpha st ...... the ODF/RANKL-RANK interaction

@en

P2093

E Jimi

http://www.w3.org/2001/XMLSchema#string

H Yasuda

http://www.w3.org/2001/XMLSchema#string

K Higashio

http://www.w3.org/2001/XMLSchema#string

K Kobayashi

http://www.w3.org/2001/XMLSchema#string

K Yamaguchi

http://www.w3.org/2001/XMLSchema#string

M Kinosaki

http://www.w3.org/2001/XMLSchema#string

N Nakagawa

http://www.w3.org/2001/XMLSchema#string

N Shima

http://www.w3.org/2001/XMLSchema#string

N Takahashi

http://www.w3.org/2001/XMLSchema#string

N Udagawa

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

The NF-kappa B and I kappa B proteins: new discoveries and insights

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

P304

275-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.191.2.275

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

191

http://www.w3.org/2001/XMLSchema#string

P50

Masamichi Takami

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10637272

http://www.w3.org/2001/XMLSchema#string

P932

2195746

http://www.w3.org/2001/XMLSchema#string